廣告
香港股市 已收市

  • 恒指

    18,475.92
    +268.79 (+1.48%)
     

  • 國指

    6,547.29
    +110.20 (+1.71%)
     

  • 上證綜指

    3,104.82
    -8.22 (-0.26%)
     

  • 滬深300

    3,604.39
    -19.52 (-0.54%)
     

  • 美元

    7.8103
    -0.0030 (-0.04%)
     

  • 人民幣

    0.9264
    +0.0003 (+0.03%)
     

  • 道指

    38,675.68
    +450.02 (+1.18%)
     

  • 標普 500

    5,127.79
    +63.59 (+1.26%)
     

  • 納指

    16,156.33
    +315.37 (+1.99%)
     

  • 日圓

    0.0508
    +0.0002 (+0.45%)
     

  • 歐元

    8.4063
    +0.0284 (+0.34%)
     

  • 英鎊

    9.7970
    +0.0050 (+0.05%)
     

  • 紐約期油

    77.99
    -0.96 (-1.22%)
     

  • 金價

    2,310.10
    +0.50 (+0.02%)
     

  • Bitcoin

    62,722.59
    +2,982.03 (+4.99%)
     

  • CMC Crypto 200

    1,359.39
    +82.41 (+6.45%)
     

Agilon (AGL) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks Equity Research
·2 分鐘文章

For the quarter ended December 2023, Agilon Health (AGL) reported revenue of $1.06 billion, up 53.1% over the same period last year. EPS came in at -$0.41, compared to -$0.14 in the year-ago quarter.

The reported revenue represents a surprise of +0.72% over the Zacks Consensus Estimate of $1.05 billion. With the consensus EPS estimate being -$0.28, the EPS surprise was -46.43%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

廣告

Here is how Agilon performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Average Medicare Advantage membership: 391,700 versus 390,592 estimated by three analysts on average.

  • Direct Contracting beneficiaries (ACO REACH): 89,300 compared to the 86,350 average estimate based on two analysts.

  • Medicare Advantage Members: 388,400 compared to the 386,200 average estimate based on two analysts.

  • Revenues- Medical services: $1.05 billion versus $1.05 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +52.9% change.

  • Revenues- Other operating: $2.53 million versus $2.50 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +175.6% change.

View all Key Company Metrics for Agilon here>>>

Shares of Agilon have returned +3.5% over the past month versus the Zacks S&P 500 composite's +3.8% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Agilon Health, Inc. (AGL) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research